Published in Crit Care on April 22, 2009
Prothrombin complex concentrates: an update. Blood Transfus (2010) 1.27
Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus (2013) 1.23
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy. Transfus Med Hemother (2012) 1.08
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Clinical use and the Italian demand for prothrombin complex concentrates. Blood Transfus (2013) 0.83
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis. J Thromb Thrombolysis (2017) 0.75
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation (2007) 5.89
Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med (1993) 4.66
Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion (2004) 4.48
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 3.65
Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med (2000) 3.60
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA (2006) 3.41
Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma (2005) 3.22
Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07
Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol (2006) 3.03
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology (2004) 2.85
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust (2004) 2.74
Management of bleeding following major trauma: a European guideline. Crit Care (2007) 2.40
Fatalities caused by TRALI. Transfus Med Rev (2004) 2.37
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol (2008) 2.27
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest (2007) 2.11
Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med (2003) 2.00
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med (2002) 1.95
Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost (2006) 1.95
Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res (2005) 1.91
Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke (2005) 1.83
Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy (2004) 1.82
Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol (2004) 1.82
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost (2008) 1.81
The management of coumarin-induced over-anticoagulation Annotation. Br J Haematol (2001) 1.73
Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol (2002) 1.71
Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol (2001) 1.60
Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke (1992) 1.48
Factor VIIa for correction of traumatic coagulopathy. J Trauma (2004) 1.43
Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost (1997) 1.41
Risk of major hemorrhage for outpatients treated with warfarin. J Gen Intern Med (1998) 1.36
Warfarin reversal. J Clin Pathol (2004) 1.33
Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang (2005) 1.31
Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke (2001) 1.26
Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med (2007) 1.20
Anticoagulants and their reversal. Transfus Med Rev (2007) 1.18
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol (2001) 1.17
Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc (2004) 1.15
Management of intracranial bleeding associated with anticoagulation: balancing the risk of further bleeding against thromboembolism from prosthetic heart valves. J Neurol Neurosurg Psychiatry (2000) 1.14
Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg (2000) 1.13
Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost (2006) 1.11
Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res (2007) 1.11
Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care (2005) 1.08
Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. Thromb Res (2004) 1.05
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth (2004) 1.04
Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers. Thromb Haemost (2007) 1.04
Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology (2008) 1.03
Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res (2007) 1.02
Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost (1998) 1.01
The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg (2003) 0.99
Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol (2003) 0.98
Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis (2007) 0.98
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med (2006) 0.96
Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res (2005) 0.96
Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res (2002) 0.94
Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? J Thromb Haemost (2006) 0.93
Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis (2004) 0.92
Emergency reversal of oral anticoagulation through PPSB-SD: the fastest procedure in Belgium. Acta Anaesthesiol Belg (2006) 0.90
Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol (2003) 0.88
The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice. Intensive Care Med (2007) 0.86
Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. J Thromb Haemost (2008) 0.85
[Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008]. J Mal Vasc (2008) 0.84
Fresh frozen plasma supplement to massive red blood cell transfusion. Ann Surg (1985) 0.81
Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal. Clin Lab Haematol (1998) 0.80
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants. Blood Coagul Fibrinolysis (2001) 0.79
Hepatitis C virus transmission through quarantine fresh-frozen plasma. Thromb Haemost (2000) 0.78
Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res (1992) 0.77
Pulmonary embolism in a patient with severe congenital deficiency for factor V during treatment with fresh frozen plasma. Haemophilia (2005) 0.76
The use of Fresh Frozen Plasma (FFP) in 2007 in France. Transfus Clin Biol (2008) 0.76
Uses of plasma in Spain. Transfus Clin Biol (2008) 0.76
9th National Conference on Anticoagulant Therapy. Preface. J Thromb Thrombolysis (2007) 0.75